

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.78736454 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.78736454 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60152845 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.60152845 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46141538 |
| 6 | leukocyte aggregation (GO:0070486) | 4.37904076 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.28108122 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00892297 |
| 9 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.77691196 |
| 10 | respiratory burst (GO:0045730) | 3.73958889 |
| 11 | detection of other organism (GO:0098543) | 3.71909538 |
| 12 | detection of bacterium (GO:0016045) | 3.71442569 |
| 13 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.61785085 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56334738 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.44748739 |
| 16 | regulation of mast cell degranulation (GO:0043304) | 3.41477607 |
| 17 | pentose-phosphate shunt (GO:0006098) | 3.36899333 |
| 18 | response to peptidoglycan (GO:0032494) | 3.34644929 |
| 19 | viral transcription (GO:0019083) | 3.32845090 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.32070271 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.32070271 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.32070271 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.32070271 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.32070271 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.32070271 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.31699284 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.30433556 |
| 28 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.29170564 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.25322054 |
| 30 | NADPH regeneration (GO:0006740) | 3.24249686 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.24215031 |
| 32 | translational termination (GO:0006415) | 3.14943973 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.13834168 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.13834168 |
| 35 | negative regulation of phagocytosis (GO:0050765) | 3.11700392 |
| 36 | cellular extravasation (GO:0045123) | 3.11415263 |
| 37 | response to type I interferon (GO:0034340) | 3.11347191 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08334179 |
| 39 | positive regulation of mast cell activation (GO:0033005) | 3.06872168 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.05773237 |
| 41 | pinocytosis (GO:0006907) | 3.05438768 |
| 42 | negative T cell selection (GO:0043383) | 3.05171222 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04100472 |
| 44 | negative thymic T cell selection (GO:0045060) | 3.04012207 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03430422 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.01603607 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01113797 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.00643634 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.00207006 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 2.97989594 |
| 51 | response to muramyl dipeptide (GO:0032495) | 2.97827421 |
| 52 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94972153 |
| 53 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94972153 |
| 54 | neutrophil activation (GO:0042119) | 2.90139474 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.89757327 |
| 56 | regulation of mast cell activation (GO:0033003) | 2.89427464 |
| 57 | B cell mediated immunity (GO:0019724) | 2.88898843 |
| 58 | membrane raft organization (GO:0031579) | 2.88308181 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87954503 |
| 60 | response to host immune response (GO:0052572) | 2.85692069 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85692069 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85174912 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83891960 |
| 64 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81280877 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81066239 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79909429 |
| 67 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.79895027 |
| 68 | protein targeting to ER (GO:0045047) | 2.79116665 |
| 69 | ribosomal small subunit biogenesis (GO:0042274) | 2.78791886 |
| 70 | cotranslational protein targeting to membrane (GO:0006613) | 2.78707316 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78274111 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 2.78257510 |
| 73 | virion attachment to host cell (GO:0019062) | 2.78257510 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 2.77468174 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 2.77056605 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76262733 |
| 77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75911353 |
| 78 | defense response to protozoan (GO:0042832) | 2.75332713 |
| 79 | activated T cell proliferation (GO:0050798) | 2.74348570 |
| 80 | T cell selection (GO:0045058) | 2.73793030 |
| 81 | amyloid precursor protein catabolic process (GO:0042987) | 2.73646251 |
| 82 | thymic T cell selection (GO:0045061) | 2.73374591 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.72063078 |
| 84 | cytidine metabolic process (GO:0046087) | 2.71617614 |
| 85 | cytidine catabolic process (GO:0006216) | 2.71617614 |
| 86 | cytidine deamination (GO:0009972) | 2.71617614 |
| 87 | ribosomal small subunit assembly (GO:0000028) | 2.71530711 |
| 88 | granulocyte activation (GO:0036230) | 2.70277292 |
| 89 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.69812477 |
| 90 | * actin nucleation (GO:0045010) | 2.69167175 |
| 91 | negative regulation of innate immune response (GO:0045824) | 2.69087119 |
| 92 | angiogenesis involved in wound healing (GO:0060055) | 2.67759009 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 2.67479076 |
| 94 | myeloid cell homeostasis (GO:0002262) | 2.66658340 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66053210 |
| 96 | positive regulation of mast cell degranulation (GO:0043306) | 2.66053210 |
| 97 | response to interleukin-15 (GO:0070672) | 2.65444225 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65259380 |
| 99 | heterotypic cell-cell adhesion (GO:0034113) | 2.64690275 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64353483 |
| 101 | response to host (GO:0075136) | 2.64353483 |
| 102 | response to host defenses (GO:0052200) | 2.64353483 |
| 103 | response to fungus (GO:0009620) | 2.63541093 |
| 104 | myeloid dendritic cell differentiation (GO:0043011) | 2.63378019 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62756207 |
| 106 | protein localization to endoplasmic reticulum (GO:0070972) | 2.62270704 |
| 107 | T cell costimulation (GO:0031295) | 2.61141945 |
| 108 | positive T cell selection (GO:0043368) | 2.61047978 |
| 109 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61011353 |
| 110 | detection of biotic stimulus (GO:0009595) | 2.60793271 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.60373640 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.60059578 |
| 113 | tolerance induction (GO:0002507) | 2.59952301 |
| 114 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.59445337 |
| 115 | viral life cycle (GO:0019058) | 2.58962837 |
| 116 | lymphocyte chemotaxis (GO:0048247) | 2.57915270 |
| 117 | translational elongation (GO:0006414) | 2.55957540 |
| 118 | macrophage differentiation (GO:0030225) | 2.55049454 |
| 119 | mannose metabolic process (GO:0006013) | 2.54650176 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54631192 |
| 121 | barbed-end actin filament capping (GO:0051016) | 2.53486159 |
| 122 | cortical actin cytoskeleton organization (GO:0030866) | 2.53448602 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 2.52966028 |
| 124 | positive regulation of macrophage differentiation (GO:0045651) | 2.51021569 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.50648914 |
| 126 | positive regulation of interleukin-17 production (GO:0032740) | 2.49149879 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 2.47746366 |
| 128 | positive regulation of lamellipodium assembly (GO:0010592) | 2.47499028 |
| 129 | leukocyte degranulation (GO:0043299) | 2.47342434 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46652153 |
| 131 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.46264213 |
| 132 | amyloid precursor protein metabolic process (GO:0042982) | 2.45667220 |
| 133 | mast cell activation (GO:0045576) | 2.45240295 |
| 134 | T cell homeostasis (GO:0043029) | 2.45096361 |
| 135 | regulation of protein heterodimerization activity (GO:0043497) | 2.43954952 |
| 136 | adhesion of symbiont to host (GO:0044406) | 2.43243976 |
| 137 | mature B cell differentiation (GO:0002335) | 2.43033164 |
| 138 | neutrophil mediated immunity (GO:0002446) | 2.41852092 |
| 139 | T cell migration (GO:0072678) | 2.40410348 |
| 140 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.38240184 |
| 141 | cellular protein complex disassembly (GO:0043624) | 2.37036876 |
| 142 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35815264 |
| 143 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.34918010 |
| 144 | positive regulation of interferon-alpha production (GO:0032727) | 2.31472547 |
| 145 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.30672264 |
| 146 | response to interferon-beta (GO:0035456) | 2.29990859 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.28993681 |
| 148 | regulation of necroptotic process (GO:0060544) | 2.28968995 |
| 149 | T cell proliferation (GO:0042098) | 2.28029400 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.28023923 |
| 151 | lymphocyte apoptotic process (GO:0070227) | 2.26106263 |
| 152 | cortical cytoskeleton organization (GO:0030865) | 2.25647660 |
| 153 | response to protozoan (GO:0001562) | 2.25568777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66370337 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52415665 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35714385 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35105773 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21249437 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07016720 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81346277 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.76869764 |
| 9 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.72837716 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72759455 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.55665236 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55216226 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52918350 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51706440 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34863074 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33640285 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.32365699 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28182923 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26508942 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25169355 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21335497 |
| 22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.21050184 |
| 23 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14960037 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12903561 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.05327887 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04296029 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.96673619 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92131840 |
| 29 | * MYC_22102868_ChIP-Seq_BL_Human | 1.89820441 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82523434 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.82383277 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81636615 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77701593 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75823656 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75672549 |
| 36 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75103423 |
| 37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74060486 |
| 38 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73046129 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69413522 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69323167 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.63874091 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63188079 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61541560 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58669735 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57902546 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57233750 |
| 47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.55609317 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52544793 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47502700 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45166081 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43634006 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.43453396 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43414120 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41168555 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40605286 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39824359 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37595494 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37595258 |
| 59 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33150084 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32327668 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32033301 |
| 62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31200411 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29277796 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28317930 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26365685 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26278189 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25611039 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24816220 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23994288 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23778952 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22839359 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20624090 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20522857 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20021554 |
| 75 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19882071 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18688185 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18350795 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16081104 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15856053 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14910623 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14363047 |
| 82 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12785503 |
| 83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12655267 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12127460 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12085307 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11469233 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11438829 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11287049 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09956817 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09753416 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09369471 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08803473 |
| 93 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.08264656 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07713871 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07358807 |
| 96 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06583423 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06505472 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05524272 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.03441917 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02616709 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00214193 |
| 102 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99990666 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99881607 |
| 104 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.99759739 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99203942 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98185607 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98028301 |
| 108 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97994900 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97855354 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97512890 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96751480 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96721002 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96376198 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95902526 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94432527 |
| 116 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94202144 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93521544 |
| 118 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93424512 |
| 119 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92443269 |
| 120 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91422223 |
| 121 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91342452 |
| 122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91237721 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90476427 |
| 124 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.90033824 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88457892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.08142414 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.91989045 |
| 3 | MP0003436_decreased_susceptibility_to | 2.85385774 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.74928881 |
| 5 | MP0000685_abnormal_immune_system | 2.62373703 |
| 6 | MP0009785_altered_susceptibility_to | 2.59563760 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.58079834 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.55819642 |
| 9 | MP0002419_abnormal_innate_immunity | 2.55612687 |
| 10 | MP0005025_abnormal_response_to | 2.43059060 |
| 11 | MP0001790_abnormal_immune_system | 2.39162515 |
| 12 | MP0005387_immune_system_phenotype | 2.39162515 |
| 13 | MP0001800_abnormal_humoral_immune | 2.35882904 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.35273512 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.21090252 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.20403987 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.19856940 |
| 18 | MP0002723_abnormal_immune_serum | 2.19388057 |
| 19 | MP0001819_abnormal_immune_cell | 2.18171301 |
| 20 | MP0005671_abnormal_response_to | 2.11341680 |
| 21 | MP0003724_increased_susceptibility_to | 2.09200673 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.08688840 |
| 23 | MP0006082_CNS_inflammation | 2.08629575 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.07519079 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.00185715 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.99969270 |
| 27 | MP0002405_respiratory_system_inflammati | 1.91840407 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.85322649 |
| 29 | MP0009278_abnormal_bone_marrow | 1.82735136 |
| 30 | MP0002933_joint_inflammation | 1.82056816 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.81186016 |
| 32 | MP0002398_abnormal_bone_marrow | 1.80134189 |
| 33 | MP0000920_abnormal_myelination | 1.79750006 |
| 34 | MP0000716_abnormal_immune_system | 1.76772439 |
| 35 | MP0004947_skin_inflammation | 1.76332555 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.68614033 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.66551792 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.59895764 |
| 39 | MP0002722_abnormal_immune_system | 1.57012563 |
| 40 | MP0001851_eye_inflammation | 1.56338329 |
| 41 | MP0003075_altered_response_to | 1.54150695 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.53642896 |
| 43 | MP0002429_abnormal_blood_cell | 1.53177258 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.50464916 |
| 45 | MP0009840_abnormal_foam_cell | 1.49414849 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.48151364 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.48151364 |
| 48 | MP0003448_altered_tumor_morphology | 1.46357534 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.46321003 |
| 50 | MP0001853_heart_inflammation | 1.45894318 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.43923339 |
| 52 | MP0005023_abnormal_wound_healing | 1.42794095 |
| 53 | MP0000858_altered_metastatic_potential | 1.41350412 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.40022755 |
| 55 | MP0000343_altered_response_to | 1.39871033 |
| 56 | MP0001873_stomach_inflammation | 1.35910526 |
| 57 | MP0001958_emphysema | 1.35108230 |
| 58 | MP0003866_abnormal_defecation | 1.29893489 |
| 59 | MP0000490_abnormal_crypts_of | 1.27274710 |
| 60 | MP0004510_myositis | 1.24947927 |
| 61 | MP0008004_abnormal_stomach_pH | 1.22714232 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.17951590 |
| 63 | MP0005310_abnormal_salivary_gland | 1.16088564 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.15152564 |
| 65 | MP0008469_abnormal_protein_level | 1.14121988 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.14073382 |
| 67 | MP0002132_abnormal_respiratory_system | 1.10946216 |
| 68 | MP0005166_decreased_susceptibility_to | 1.10851470 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.10493671 |
| 70 | MP0002006_tumorigenesis | 1.09341900 |
| 71 | MP0003279_aneurysm | 1.07057761 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.06985993 |
| 73 | MP0010307_abnormal_tumor_latency | 1.06088321 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.05375123 |
| 75 | MP0006054_spinal_hemorrhage | 1.04543356 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.03530851 |
| 77 | MP0003091_abnormal_cell_migration | 1.03322647 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.01088658 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.96652167 |
| 80 | MP0000604_amyloidosis | 0.96627200 |
| 81 | MP0003690_abnormal_glial_cell | 0.95364082 |
| 82 | MP0005390_skeleton_phenotype | 0.94823434 |
| 83 | MP0001243_abnormal_dermal_layer | 0.91016561 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.89494090 |
| 85 | MP0000383_abnormal_hair_follicle | 0.88301617 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.87538464 |
| 87 | MP0003828_pulmonary_edema | 0.86959749 |
| 88 | MP0004883_abnormal_blood_vessel | 0.85668893 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.84801074 |
| 90 | MP0004381_abnormal_hair_follicle | 0.81595451 |
| 91 | MP0000249_abnormal_blood_vessel | 0.80028505 |
| 92 | MP0000733_abnormal_muscle_development | 0.79482513 |
| 93 | MP0005165_increased_susceptibility_to | 0.78993746 |
| 94 | MP0003795_abnormal_bone_structure | 0.78232767 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.77471874 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.74329165 |
| 97 | MP0005275_abnormal_skin_tensile | 0.74261085 |
| 98 | MP0005164_abnormal_response_to | 0.73738708 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.72828595 |
| 100 | MP0008260_abnormal_autophagy | 0.70643143 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.69653430 |
| 102 | MP0009763_increased_sensitivity_to | 0.69230686 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.68128531 |
| 104 | MP0005451_abnormal_body_composition | 0.68091934 |
| 105 | MP0001663_abnormal_digestive_system | 0.68048068 |
| 106 | MP0008874_decreased_physiological_sensi | 0.67617844 |
| 107 | MP0009764_decreased_sensitivity_to | 0.67591427 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.64913826 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.64852474 |
| 110 | MP0002060_abnormal_skin_morphology | 0.64712321 |
| 111 | MP0001542_abnormal_bone_strength | 0.64412356 |
| 112 | MP0000377_abnormal_hair_follicle | 0.64171353 |
| 113 | MP0005083_abnormal_biliary_tract | 0.62325867 |
| 114 | MP0003045_fibrosis | 0.62245295 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.59185892 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56291629 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.53863074 |
| 118 | MP0000609_abnormal_liver_physiology | 0.53177506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.12914716 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.68472365 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28116941 |
| 4 | Chronic otitis media (HP:0000389) | 4.22567173 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.14754506 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.12708385 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.03863876 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.61486159 |
| 9 | Cellulitis (HP:0100658) | 3.57678655 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43083300 |
| 11 | Obstructive lung disease (HP:0006536) | 3.43083300 |
| 12 | Myositis (HP:0100614) | 3.33344978 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.32299738 |
| 14 | Recurrent skin infections (HP:0001581) | 3.28458774 |
| 15 | Petechiae (HP:0000967) | 3.16901639 |
| 16 | IgM deficiency (HP:0002850) | 3.14944124 |
| 17 | Increased IgM level (HP:0003496) | 3.13104782 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.09686041 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.07450317 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.06689878 |
| 21 | Stomatitis (HP:0010280) | 3.04054277 |
| 22 | Optic neuritis (HP:0100653) | 3.00579258 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.00579258 |
| 24 | Premature rupture of membranes (HP:0001788) | 2.93756163 |
| 25 | Encephalitis (HP:0002383) | 2.92502244 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.91794590 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.91794590 |
| 28 | Recurrent viral infections (HP:0004429) | 2.82309409 |
| 29 | Thrombocytosis (HP:0001894) | 2.81931823 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.73924003 |
| 31 | Hepatosplenomegaly (HP:0001433) | 2.71394942 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.71182530 |
| 33 | Nasal polyposis (HP:0100582) | 2.70598900 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68934044 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.68143304 |
| 36 | Increased serum ferritin (HP:0003281) | 2.66403905 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.64789038 |
| 38 | Loss of speech (HP:0002371) | 2.64310846 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.64301717 |
| 40 | Pustule (HP:0200039) | 2.62002819 |
| 41 | Peritonitis (HP:0002586) | 2.61573599 |
| 42 | Purpura (HP:0000979) | 2.59233582 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.58323654 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.56766118 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.56200327 |
| 46 | Meningitis (HP:0001287) | 2.54482044 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53748049 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53748049 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53748049 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.49860867 |
| 51 | Chest pain (HP:0100749) | 2.49026554 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.48851893 |
| 53 | Leukocytosis (HP:0001974) | 2.47893291 |
| 54 | Parakeratosis (HP:0001036) | 2.47655131 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.47650557 |
| 56 | Vasculitis (HP:0002633) | 2.44666181 |
| 57 | Gastrointestinal stroma tumor (HP:0100723) | 2.42233068 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.35089877 |
| 59 | Menorrhagia (HP:0000132) | 2.34711847 |
| 60 | Osteomyelitis (HP:0002754) | 2.31142596 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.30577363 |
| 62 | Hemoptysis (HP:0002105) | 2.29831738 |
| 63 | Colitis (HP:0002583) | 2.27690757 |
| 64 | Abnormality of iron homeostasis (HP:0011031) | 2.26768891 |
| 65 | Protrusio acetabuli (HP:0003179) | 2.24807751 |
| 66 | Emphysema (HP:0002097) | 2.23548754 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.23219756 |
| 68 | Increased IgE level (HP:0003212) | 2.21914568 |
| 69 | Orchitis (HP:0100796) | 2.21116144 |
| 70 | Increased mean platelet volume (HP:0011877) | 2.19602266 |
| 71 | Eosinophilia (HP:0001880) | 2.19357990 |
| 72 | Gingivitis (HP:0000230) | 2.18587304 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.17903124 |
| 74 | Urticaria (HP:0001025) | 2.17221222 |
| 75 | Arterial thrombosis (HP:0004420) | 2.16534770 |
| 76 | Thoracic kyphosis (HP:0002942) | 2.15786600 |
| 77 | Hypertensive crisis (HP:0100735) | 2.15460481 |
| 78 | Amyloidosis (HP:0011034) | 2.14822214 |
| 79 | Abnormality of the lumbar spine (HP:0100712) | 2.14325471 |
| 80 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13962393 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13962393 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.13717855 |
| 83 | Spondylolisthesis (HP:0003302) | 2.10509160 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.10431830 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10431830 |
| 86 | Skin ulcer (HP:0200042) | 2.10260185 |
| 87 | Episodic fever (HP:0001954) | 2.09726930 |
| 88 | Lymphopenia (HP:0001888) | 2.09675692 |
| 89 | Axonal loss (HP:0003447) | 2.07385252 |
| 90 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.07171563 |
| 91 | T lymphocytopenia (HP:0005403) | 2.04815410 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03041305 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.02793346 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 2.01752762 |
| 95 | Restrictive lung disease (HP:0002091) | 2.01711228 |
| 96 | Abnormal platelet volume (HP:0011876) | 1.99287378 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 1.99196006 |
| 98 | Abnormality of T cells (HP:0002843) | 1.98973603 |
| 99 | J-shaped sella turcica (HP:0002680) | 1.98803290 |
| 100 | Granulocytopenia (HP:0001913) | 1.98343707 |
| 101 | IgG deficiency (HP:0004315) | 1.98090220 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.97859272 |
| 103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97217808 |
| 104 | Chronic diarrhea (HP:0002028) | 1.96839198 |
| 105 | Glomerulopathy (HP:0100820) | 1.96475277 |
| 106 | Stridor (HP:0010307) | 1.96427073 |
| 107 | Pulmonary embolism (HP:0002204) | 1.96421806 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.96133168 |
| 109 | Recurrent pneumonia (HP:0006532) | 1.96108846 |
| 110 | Joint swelling (HP:0001386) | 1.95128896 |
| 111 | Increased density of long bones (HP:0006392) | 1.94482691 |
| 112 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94269958 |
| 113 | Abnormality of eosinophils (HP:0001879) | 1.94031717 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92729365 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.92508196 |
| 116 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91203055 |
| 117 | Skin rash (HP:0000988) | 1.91202906 |
| 118 | Arthralgia (HP:0002829) | 1.90670457 |
| 119 | Aortic dissection (HP:0002647) | 1.90164735 |
| 120 | Epistaxis (HP:0000421) | 1.89722076 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.89075617 |
| 122 | Abnormal platelet function (HP:0011869) | 1.89075617 |
| 123 | Hematochezia (HP:0002573) | 1.88777169 |
| 124 | Abnormal number of erythroid precursors (HP:0012131) | 1.85641399 |
| 125 | Gingival bleeding (HP:0000225) | 1.85569561 |
| 126 | Panhypogammaglobulinemia (HP:0003139) | 1.85095036 |
| 127 | Abnormality of the peritoneum (HP:0002585) | 1.83959242 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83227326 |
| 129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83227326 |
| 130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83227326 |
| 131 | Ulnar bowing (HP:0003031) | 1.82696809 |
| 132 | Cervical subluxation (HP:0003308) | 1.82226323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.78064019 |
| 2 | EPHB1 | 3.33212184 |
| 3 | BLK | 2.98599528 |
| 4 | NME2 | 2.96561890 |
| 5 | TESK2 | 2.81900138 |
| 6 | IRAK4 | 2.30217944 |
| 7 | KIT | 2.29089665 |
| 8 | STK10 | 2.26199851 |
| 9 | PRPF4B | 2.04184604 |
| 10 | BTK | 1.95437663 |
| 11 | LRRK2 | 1.92393967 |
| 12 | TBK1 | 1.91942579 |
| 13 | PIM2 | 1.91001971 |
| 14 | ERN1 | 1.85380641 |
| 15 | CSF1R | 1.82364926 |
| 16 | JAK3 | 1.74531791 |
| 17 | ZAP70 | 1.70582995 |
| 18 | MST4 | 1.64574973 |
| 19 | TYK2 | 1.61881336 |
| 20 | KDR | 1.61064028 |
| 21 | STK39 | 1.59845747 |
| 22 | TRIB3 | 1.56843466 |
| 23 | FES | 1.56121247 |
| 24 | CSK | 1.55375195 |
| 25 | TAOK2 | 1.51611616 |
| 26 | LIMK1 | 1.48534420 |
| 27 | TEC | 1.46482687 |
| 28 | PKN2 | 1.44932420 |
| 29 | CLK1 | 1.44141824 |
| 30 | ITK | 1.44107620 |
| 31 | TNK2 | 1.36498590 |
| 32 | EEF2K | 1.34077679 |
| 33 | TRPM7 | 1.31204671 |
| 34 | MAP2K3 | 1.26259636 |
| 35 | LCK | 1.25812863 |
| 36 | IKBKB | 1.24520813 |
| 37 | TXK | 1.24046759 |
| 38 | FGR | 1.20329078 |
| 39 | TESK1 | 1.20181796 |
| 40 | IKBKE | 1.19923410 |
| 41 | HCK | 1.18465398 |
| 42 | TGFBR2 | 1.16199158 |
| 43 | SYK | 1.15338650 |
| 44 | TAOK1 | 1.14518175 |
| 45 | TTN | 1.12743534 |
| 46 | RPS6KA4 | 1.09309662 |
| 47 | PAK4 | 1.09168195 |
| 48 | ARAF | 1.06758159 |
| 49 | MAP3K11 | 1.05908381 |
| 50 | BMPR2 | 0.99313790 |
| 51 | MAP3K1 | 0.99141313 |
| 52 | MAP3K8 | 0.98671712 |
| 53 | LYN | 0.97657618 |
| 54 | SMG1 | 0.96530274 |
| 55 | FLT3 | 0.94184044 |
| 56 | TLK1 | 0.93559098 |
| 57 | SIK3 | 0.92280206 |
| 58 | MET | 0.90879336 |
| 59 | IRAK3 | 0.88785660 |
| 60 | BCKDK | 0.86747957 |
| 61 | EIF2AK3 | 0.86452180 |
| 62 | PIM1 | 0.86285389 |
| 63 | PBK | 0.85221198 |
| 64 | GRK6 | 0.83431336 |
| 65 | SCYL2 | 0.80828419 |
| 66 | CDK19 | 0.80365953 |
| 67 | MAP3K14 | 0.79271373 |
| 68 | MAPKAPK3 | 0.78040376 |
| 69 | RPS6KB2 | 0.77093766 |
| 70 | JAK1 | 0.73429227 |
| 71 | GRK7 | 0.71566661 |
| 72 | PDK1 | 0.69680150 |
| 73 | PDPK1 | 0.68275118 |
| 74 | NLK | 0.68044218 |
| 75 | MATK | 0.67887933 |
| 76 | CDC42BPA | 0.67021155 |
| 77 | SIK1 | 0.65175152 |
| 78 | PRKD2 | 0.63289532 |
| 79 | MOS | 0.62558792 |
| 80 | BMX | 0.62459425 |
| 81 | IRAK1 | 0.61817730 |
| 82 | BUB1 | 0.61004344 |
| 83 | MAPKAPK5 | 0.59607157 |
| 84 | MAP2K2 | 0.59526988 |
| 85 | CSNK1G3 | 0.59322988 |
| 86 | STK4 | 0.58508468 |
| 87 | PRKCQ | 0.57981183 |
| 88 | MAPKAPK2 | 0.57368128 |
| 89 | PAK2 | 0.56102411 |
| 90 | TAOK3 | 0.55195697 |
| 91 | ROCK2 | 0.54706286 |
| 92 | PTK6 | 0.54610201 |
| 93 | OXSR1 | 0.54385950 |
| 94 | EPHA3 | 0.54071951 |
| 95 | ABL1 | 0.53559091 |
| 96 | ABL2 | 0.52935289 |
| 97 | TNIK | 0.52831186 |
| 98 | FGFR4 | 0.51418599 |
| 99 | CSNK1A1L | 0.51336721 |
| 100 | RPS6KA5 | 0.50986998 |
| 101 | ILK | 0.50898071 |
| 102 | MARK3 | 0.49992343 |
| 103 | MAPK12 | 0.49788064 |
| 104 | MAPK11 | 0.47759660 |
| 105 | MAP3K3 | 0.47201866 |
| 106 | NEK9 | 0.47121309 |
| 107 | MAP3K13 | 0.46942512 |
| 108 | JAK2 | 0.46471972 |
| 109 | * PAK1 | 0.46445210 |
| 110 | DAPK1 | 0.45461385 |
| 111 | PTK2B | 0.44870337 |
| 112 | TGFBR1 | 0.44812325 |
| 113 | RIPK4 | 0.44740720 |
| 114 | MAP3K10 | 0.43957425 |
| 115 | WEE1 | 0.43911636 |
| 116 | CAMKK2 | 0.41979446 |
| 117 | EIF2AK1 | 0.41273026 |
| 118 | MYLK | 0.41141222 |
| 119 | PRKG2 | 0.40573479 |
| 120 | MAP3K5 | 0.39334725 |
| 121 | FYN | 0.38183630 |
| 122 | CSNK1G1 | 0.38001461 |
| 123 | IRAK2 | 0.37811704 |
| 124 | PIK3CG | 0.37441480 |
| 125 | MAPK4 | 0.37440846 |
| 126 | CDK4 | 0.37167283 |
| 127 | HIPK2 | 0.36975196 |
| 128 | PRKCD | 0.36720287 |
| 129 | MAP2K6 | 0.35940703 |
| 130 | NEK2 | 0.35175598 |
| 131 | KSR2 | 0.34632646 |
| 132 | RPS6KC1 | 0.33620349 |
| 133 | RPS6KL1 | 0.33620349 |
| 134 | MAP3K6 | 0.32885396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.39466517 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35785451 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.26671421 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.21832558 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10260787 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05160454 |
| 7 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98426870 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.96576134 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.88436937 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86927065 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85464075 |
| 12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.83614824 |
| 13 | * Shigellosis_Homo sapiens_hsa05131 | 1.81255081 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81025676 |
| 15 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.76068887 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72430973 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68084722 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62860307 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.59147992 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.58983540 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.55382065 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.54533910 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49953700 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46437744 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44514473 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44266987 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39241081 |
| 28 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38360334 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.34561394 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.32953842 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32158453 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.30297619 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27651635 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27488779 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.27302983 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26491195 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24888252 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23750355 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20192394 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18279750 |
| 41 | * Salmonella infection_Homo sapiens_hsa05132 | 1.18158537 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.17224190 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13051648 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11203173 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.09479960 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09292260 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09286996 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05274316 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02288439 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01569325 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01380438 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00798692 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.00467545 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99794739 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98554616 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.97040330 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96545670 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94229875 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94118134 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93677496 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93124740 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92461073 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91598410 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.89315495 |
| 65 | * Endocytosis_Homo sapiens_hsa04144 | 0.86172289 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83292909 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83230404 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.83168300 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81312584 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80702559 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79433085 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76572824 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76545555 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.76208020 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75746248 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75314586 |
| 77 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74304154 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74011858 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73987496 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.73132479 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.71514089 |
| 82 | Homologous recombination_Homo sapiens_hsa03440 | 0.71389237 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71324786 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.69995766 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.68978408 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67907003 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65214729 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65088833 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64920145 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64532976 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62924055 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59391337 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59049161 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58925750 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58695573 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58302043 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56918741 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56483832 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56117946 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56096686 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.55989924 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55362036 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54850403 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.54142145 |
| 105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52878972 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52830820 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.51840379 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51781749 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51145593 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51103537 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50688762 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49781893 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39688680 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.36671192 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36480066 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35603114 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32871981 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29422656 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26689948 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26030686 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21987565 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21087969 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20833343 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15322674 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.14399575 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12630853 |

